Romanian PM calls for creation of a national reserve of drugs for emergency situations

Newsroom 24/02/2012 | 12:04

The Ministry of Health must carry out within one week an analysis regarding the creation of a national reserve that should include all the drugs for emergency situations, as required by the Romanian prime- minister.

“Currently, there is such a reserve but only for special situations, which do not cover also the lack of drug stocks in hospitals,” said sources quoted by Mediafax newswire.

In a special meeting on Thursday, the government allocated from the reserve fund RON 750,000 for the urgent acquisition of drugs necessary for the treatment of cancer patients.

This follows after Mundipharma, the company that supplies morphine drugs in Romania, announced earlier this week that it will undergo reorganization. The firm assured that there would not be any issues with the supply of medicines, but the slow rate of imports caused a hiatus in the supply process, creating a lack of medicines that will be covered within 10-15 days, according to Vasile Cepoi, state secretary in the Health Ministry.

“We did not think that such a hiatus would appear in the supply of medicines, but most likely we will make a reserve for such situations as well. Such a situation has never occurred before,” said Cepoi.

Otilia Haraga

BR Magazine | Latest Issue

Download PDF or read online: November 2022 Issue | Business Review Magazine

The November 2022 issue of Business Review Magazine is now available in digital format, featuring the main cover story titled “Samsung Remains Top Consumer Tech Provider on Romanian Market.” Read
Newsroom | 29/11/2022 | 10:17

    You will receive a download link for the latest issue of Business Review Magazine in PDF format, based on the completion of the form below.

    I agree with the Privacy policy of
    I agree with the storage and handling of my data by
    Advertisement Advertisement
    Close ×

    We use cookies for keeping our website reliable and secure, personalising content and ads, providing social media features and to analyse how our website is used.

    Accept & continue